openPR Logo
Press release

Roaring Kitty Expands Horizons: Key Stocks to Watch as Influencer Shakes Up Market: CHWY, DYAI, WOOF, VTAK, INBS

07-02-2024 05:06 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Roaring Kitty Expands Horizons: Key Stocks to Watch as

The influencer 'Roaring Kitty' shook the stock markets with the 'meme stock' phenomenon, with GameStop, Inc. (NYSE: GME) becoming his most notable trade. Meme stocks have generated substantial wealth for traders, and it seems Roaring Kitty is now broadening his scope. This feature offers insight into the stock's worth monitoring in light of Roaring Kitty's latest moves.

Chewy Inc. (NASDAQ: CHWY): Chewy experienced significant volatility on July 1 after a regulatory filing revealed that Roaring Kitty acquired a 6.6% stake. Roaring Kitty bought 9 million shares of the pet retailer, totaling over $261 million at a closing price of $29.05 per share on June 28. This made him the third-largest shareholder, with the stock gaining over 20% before markets opened on July 1.

Dyadic International Inc. (NASDAQ: DYAI): Dyadic International, a leader in cell culture solutions, announced a strategic partnership with Proliant Health and Biologicals (PHB) last month. PHB will provide $1.5 million upfront for developing high-volume, cost-effective cell culture products set to enter the $6 billion serum albumin market in the first half of 2025. Zacks SmallCap valued Dyadic at $9 a share in a July 1 report. [https://s27.q4cdn.com/906368049/files/News/2024/Zacks_SCR_Research_07012024_DYAI_Vandermosten.pdf]

Petco Health and Wellness Company Inc. (NASDAQ: WOOF): Petco released its 2023 ESG report last month, highlighting its commitment to pet owners, pets, and employees. The Petco Love initiative found homes for 142,924 pets in the 2023 fiscal year and donated $33.5 million to 2,000 animal welfare organizations and shelters. Petco also expanded its in-store veterinary hospitals to over 280 locations.

Catheter Precision Inc. (NYSE AMERICAN: VTAK) saw its stock surge 43.58% on July 1, reaching an intraday high of $0.84 per share before pulling back over 50% to $0.38, creating a potential buying opportunity. This followed the announcement of unaudited revenues for the fiscal quarter and six months ended June 30, 2024. The company reported sales of its innovative LockeT and VIVO products. The VIVO system, a non-invasive 3D imaging technology, enhances the efficiency of ventricular ablation, aligning with the company's expansion strategy. Read Entire Update Now! [https://thestreetreports.com/cutting-edge-medical-innovations-propel-catheter-precision-inc-nyse-american-vtak-forward/]

Catheter Precision Inc. (NYSE AMERICAN: VTAK) saw its stock surge 43.58% on July 1, reaching an intraday high of $0.84 per share before pulling back over 50% to $0.38, creating a potential buying opportunity. This followed the announcement of unaudited revenues for the fiscal quarter and six months ended June 30, 2024. The company reported sales of its innovative LockeT and VIVO products. The VIVO system, a non-invasive 3D imaging technology, enhances the efficiency of ventricular ablation, aligning with the company's expansion strategy. [https://thestreetreports.com/cutting-edge-medical-innovations-propel-catheter-precision-inc-nyse-american-vtak-forward/]

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=roaring-kitty-expands-horizons-key-stocks-to-watch-as-influencer-shakes-up-market-chwy-dyai-woof-vtak-inbs]
Country: United States
Website: http://www.thestreetreports.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Roaring Kitty Expands Horizons: Key Stocks to Watch as Influencer Shakes Up Market: CHWY, DYAI, WOOF, VTAK, INBS here

News-ID: 3562315 • Views:

More Releases from ABNewswire

How to Pick the Best Online Chemistry Tutoring Platform
How to Pick the Best Online Chemistry Tutoring Platform
Image: https://www.abnewswire.com/upload/2025/10/814f4b38d9855ce5fcc0509bfebaa240.jpg Choosing the right chemistry tutoring platform can make the difference between academic success and continued struggles with complex reactions and molecular structures. With students increasingly turning to digital solutions for personalized learning support, the online chemistry tutoring market has exploded with options promising everything from AI-powered progress tracking to virtual lab experiences that transform how learners approach this challenging subject. Essential Platform Features for Effective Online Chemistry Tutoring Modern chemistry tutoring
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical De …
DelveInsight's, "Diabetic Retinopathy Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Retinopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight
Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Macular Edema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our

All 5 Releases


More Releases for Roaring

Roaring Penguin Software releases CanIt 10.1.5
13 June 2017 – Ottawa, Ontario, Canada – Roaring Penguin Software Inc., the email filtering experts, makers of the acclaimed CanIt-PRO, CanIt-Domain-PRO, CanIt Archiver and Hosted CanIt anti-spam outbound filtering, email encryption and email archiving solutions, announce the release of CanIt 10.1.5. CanIt 10.1.5. improves e-mail security, particularly with improvements to CanIt’s Custom Rules and user interface. CanIt 10.1.5 provides the following new features: URLs re-written by the URL Proxy feature are
Roaring Penguin Software Releases CanIt 10.0.2
August 2016 – Ottawa, Ontario, Canada – Roaring Penguin Software Inc., the email filtering experts, makers of the acclaimed CanIt-PRO, CanIt-Domain-PRO, CanIt Archiver and Hosted CanIt anti-spam outbound filtering, email encryption and email archiving solutions, announce the release of CanIt 10.0.2 CanIt 10.0.2 provides the following new features: The Locked Addresses feature has been enhanced with a variation called "Immediate Locked Addresses" that lets you create a locked address without logging into
Roaring Penguin Software releases CanIt 10.0.1
CanIt 10.0.1 Improves Autotask® Integration, Delivery Policy Rules 24 June 2016 – Ottawa, Ontario, Canada – Roaring Penguin Software Inc., the email filtering experts, makers of the acclaimed CanIt-PRO, CanIt-Domain-PRO, CanIt Archiver and Hosted CanIt anti-spam outbound filtering, email encryption and email archiving solutions, announce the release of CanIt 10.0.1. Recent changes in the antispam marketplace, including Intel/McAfee’s end-of-life of their MX Logic product and eFolder’s end-of-life of their DoubleCheck product
Roaring Penguin Software to Participate in Webinar with Ulistic
Roaring Penguin Software Inc, makers of the acclaimed CanIt line of anti-spam solutions, today announced that they will participate in an online webinar with Ulistic. The webinar will feature David Skoll, President and CTO of Roaring Penguin Software, and Stuart Crawford, President of Ulistic. The webinar will focus on increasing profitability in anti-spam sales and on automating management of anti-spam. “We are very excited about the integration with Autotask's billing module,” said
Roaring Penguin Software to Participate in Webinar with Autotask
Roaring Penguin Software Inc, makers of the acclaimed CanIt line of anti-spam solutions, today announced that they will participate in an online Webinar with Autotask, the world’s leading IT business management platform delivered from the cloud. The Webinar will feature David Skoll, President and CTO of Roaring Penguin Software and Len DiConstanzo, VP Business Development of Autotask. The Webinar will focus on increasing profitability in anti-spam sales and on automating the
Roaring Penguin Software Announces Hosted CanIt Integration with Autotask
Roaring Penguin Software Inc., makers of the acclaimed CanIt line of anti-spam solutions, today announced that they have completed integration of their Hosted CanIt anti-spam software service with Autotask, the world’s leading IT business management platform delivered from the cloud. CanIt now tightly integrates with Autotask, allowing MSPs and IT Service Providers to bill anti-spam users from within Autotask. The MSP can identify how many e-mail addresses have been seen for